Central nervous system side-effects of 5-HT 3-receptor antagonists in elderly cancer patients treated with chemotherapy [1]

Annals of Oncology

Volumn 15, Issue 6, 2004, Pages 987-988

  Tralongo, Paolo ^a   Dimari, A ^a   Conti, G ^a   Aiello, R ^b   Mauceri, G ^a  

^a G Di Maria Hospital   (Italy)

^b Centro Catanese di Oncologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DICLOFENAC; EPIRUBICIN; GRANISETRON; ONDANSETRON; PRAVASTATIN; RABEPRAZOLE; SEROTONIN 3 ANTAGONIST;

AGED; CANCER PATIENT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIZZINESS; ELDERLY CARE; HEADACHE; HUMAN; INTERVIEW; LETTER; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; NAUSEA AND VOMITING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; VISUAL IMPAIRMENT;

AGED; ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; CLINICAL TRIALS; GRANISETRON; HUMANS; NEOPLASMS; ONDANSETRON; SEROTONIN ANTAGONISTS;

EID: 3442882842     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh223     Document Type: Letter

References (6)

1. Del Giglio A, Soares HP, Caparroz C et al. Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomit. Results of a meta-analysis of randomised controlled trials. Cancer 2000; 89: 2301-2308.
2. Grunberg SM. Phase I and other dose-ranging studies of granisetron. Semin Oncol 1992; 19 (Suppl 10): 16-22.
3. Perez EA, Hesketh P, Sandbach J et al. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicentric, double-blind, randomised parallel study. J Clin Oncol 1998; 16: 754-760.
4. Perez EA, Lembersky B, Kaywin P et al. Comparable safety and antiemetic efficacy of a brief (30-sec bolus) intravenous granisetron infusion and standard (15-min) intravenous ondansetron infusion in breast cancer patients receiving moderately chemotherapy. Cancer J Sci Am 1998; 4: 52-58.
5. Blower P. A pharmacological profile of oral granisetron (Kytril tablets). Semin Oncol 1995; 4 (Suppl 10): 3-5.
6. Tyers MB, Bunce KT, Humphrey PP. Pharmacological and anti-emetic properties of ondansetron. Eur J Cancer Clin Oncol 1989; 25 (Suppl 1): S15-S19.